BPA is defined as a class of chemicals which are known as endocrine disruptors as they can potentially affect normal hormone functions, decrease fertility, and they could be linked to increased cancer risk.
And while manufactures’ attempts to remove BPA from commonly used products it continues to be frequently used and according to a new study, the findings suggest that the U.S. Food and Drug Administration (FDA) has significantly underestimated humans’ exposure to the chemical.
The authors explain in the study, which was published in The Lancet Diabetes & Endocrinology, how the the tools to measure BPA levels are not correct.
But as estimates of human exposure have been based on methods from indirect methods, these findings prove that human exposure to BPA is much higher than has been assumed previously.
“Because negligible exposure levels have been a cornerstone of regulatory decisions, including the FDA conclusion that BPA poses little health risk, the present data raise urgent concerns that risks to human health have also been dramatically underestimated.”
This new study could change the way that both scientists and regulatory agencies understand past studies that have attempted to measure BPA exposure and in addition, change the way BPA levels are measured.